nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—coronary artery disease—atherosclerosis	0.348	1	CtDrD
Captopril—LTA4H—atherosclerosis	0.196	0.54	CbGaD
Captopril—MMP2—atherosclerosis	0.0533	0.147	CbGaD
Captopril—F2—atherosclerosis	0.0455	0.125	CbGaD
Captopril—MMP9—atherosclerosis	0.0351	0.0965	CbGaD
Captopril—ACE—atherosclerosis	0.0238	0.0655	CbGaD
Captopril—SLC22A6—Pravastatin—atherosclerosis	0.0204	0.179	CbGbCtD
Captopril—ALB—Rosuvastatin—atherosclerosis	0.0191	0.168	CbGbCtD
Captopril—CYP2D6—Niacin—atherosclerosis	0.0111	0.0972	CbGbCtD
Captopril—ABCB1—Ezetimibe—atherosclerosis	0.01	0.0877	CbGbCtD
Captopril—ALB—atherosclerosis	0.00975	0.0268	CbGaD
Captopril—ABCB1—Simvastatin—atherosclerosis	0.0093	0.0815	CbGbCtD
Captopril—ABCB1—Pravastatin—atherosclerosis	0.0091	0.0798	CbGbCtD
Captopril—ABCB1—Lovastatin—atherosclerosis	0.0091	0.0798	CbGbCtD
Captopril—CYP2D6—Simvastatin—atherosclerosis	0.00876	0.0768	CbGbCtD
Captopril—CYP2D6—Lovastatin—atherosclerosis	0.00858	0.0752	CbGbCtD
Captopril—CYP2D6—Pravastatin—atherosclerosis	0.00858	0.0752	CbGbCtD
Captopril—REN—abdominal aorta—atherosclerosis	0.00638	0.119	CbGeAlD
Captopril—REN—renal artery—atherosclerosis	0.00411	0.0767	CbGeAlD
Captopril—REN—arteriole—atherosclerosis	0.0033	0.0616	CbGeAlD
Captopril—MMP9—middle cerebral artery—atherosclerosis	0.00299	0.0559	CbGeAlD
Captopril—ACE—thoracic aorta—atherosclerosis	0.00216	0.0403	CbGeAlD
Captopril—MMP2—tunica intima—atherosclerosis	0.00215	0.0402	CbGeAlD
Captopril—REN—vein—atherosclerosis	0.00197	0.0367	CbGeAlD
Captopril—MMP9—tunica intima—atherosclerosis	0.00187	0.035	CbGeAlD
Captopril—ACE—renal artery—atherosclerosis	0.00175	0.0327	CbGeAlD
Captopril—ACE—arteriole—atherosclerosis	0.00141	0.0263	CbGeAlD
Captopril—F2—vein—atherosclerosis	0.00137	0.0256	CbGeAlD
Captopril—MMP2—hindlimb—atherosclerosis	0.0012	0.0224	CbGeAlD
Captopril—REN—appendage—atherosclerosis	0.00112	0.0209	CbGeAlD
Captopril—MMP9—hindlimb—atherosclerosis	0.00105	0.0195	CbGeAlD
Captopril—MMP2—appendage—atherosclerosis	0.00103	0.0192	CbGeAlD
Captopril—F2—leg—atherosclerosis	0.00102	0.0191	CbGeAlD
Captopril—ACE—tunica intima—atherosclerosis	0.000998	0.0186	CbGeAlD
Captopril—F2—hindlimb—atherosclerosis	0.000912	0.017	CbGeAlD
Captopril—MMP9—appendage—atherosclerosis	0.000897	0.0167	CbGeAlD
Captopril—ACE—vein—atherosclerosis	0.000839	0.0157	CbGeAlD
Captopril—REN—artery—atherosclerosis	0.000802	0.015	CbGeAlD
Captopril—F2—appendage—atherosclerosis	0.000782	0.0146	CbGeAlD
Captopril—MMP2—artery—atherosclerosis	0.000737	0.0138	CbGeAlD
Captopril—MMP9—artery—atherosclerosis	0.000641	0.012	CbGeAlD
Captopril—REN—blood vessel—atherosclerosis	0.000624	0.0117	CbGeAlD
Captopril—MMP2—endothelium—atherosclerosis	0.000622	0.0116	CbGeAlD
Captopril—ACE—umbilical vein—atherosclerosis	0.000609	0.0114	CbGeAlD
Captopril—MMP2—blood vessel—atherosclerosis	0.000574	0.0107	CbGeAlD
Captopril—F2—artery—atherosclerosis	0.000559	0.0104	CbGeAlD
Captopril—ACE—hindlimb—atherosclerosis	0.000557	0.0104	CbGeAlD
Captopril—MMP9—endothelium—atherosclerosis	0.000541	0.0101	CbGeAlD
Captopril—MMP9—blood vessel—atherosclerosis	0.000499	0.00932	CbGeAlD
Captopril—ACE—appendage—atherosclerosis	0.000478	0.00892	CbGeAlD
Captopril—F2—endothelium—atherosclerosis	0.000472	0.00882	CbGeAlD
Captopril—F2—blood vessel—atherosclerosis	0.000436	0.00813	CbGeAlD
Captopril—Enalapril—ACE—atherosclerosis	0.000428	1	CrCbGaD
Captopril—LTA4H—connective tissue—atherosclerosis	0.000415	0.00774	CbGeAlD
Captopril—LTA4H—cardiovascular system—atherosclerosis	0.000361	0.00674	CbGeAlD
Captopril—ACE—artery—atherosclerosis	0.000342	0.00638	CbGeAlD
Captopril—REN—connective tissue—atherosclerosis	0.00032	0.00598	CbGeAlD
Captopril—LTA4H—adipose tissue—atherosclerosis	0.000318	0.00594	CbGeAlD
Captopril—MMP2—connective tissue—atherosclerosis	0.000294	0.00549	CbGeAlD
Captopril—ACE—endothelium—atherosclerosis	0.000289	0.00539	CbGeAlD
Captopril—REN—cardiovascular system—atherosclerosis	0.000279	0.0052	CbGeAlD
Captopril—ACE—blood vessel—atherosclerosis	0.000266	0.00497	CbGeAlD
Captopril—MMP2—cardiovascular system—atherosclerosis	0.000256	0.00478	CbGeAlD
Captopril—MMP9—connective tissue—atherosclerosis	0.000256	0.00478	CbGeAlD
Captopril—MMP2—adipose tissue—atherosclerosis	0.000226	0.00421	CbGeAlD
Captopril—F2—connective tissue—atherosclerosis	0.000223	0.00417	CbGeAlD
Captopril—LTA4H—liver—atherosclerosis	0.000223	0.00417	CbGeAlD
Captopril—MMP9—cardiovascular system—atherosclerosis	0.000223	0.00416	CbGeAlD
Captopril—MMP9—adipose tissue—atherosclerosis	0.000196	0.00367	CbGeAlD
Captopril—F2—cardiovascular system—atherosclerosis	0.000194	0.00363	CbGeAlD
Captopril—Eosinophilia—Simvastatin—atherosclerosis	0.000193	0.00349	CcSEcCtD
Captopril—Erectile dysfunction—Lovastatin—atherosclerosis	0.000192	0.00347	CcSEcCtD
Captopril—Pancreatitis—Simvastatin—atherosclerosis	0.000191	0.00345	CcSEcCtD
Captopril—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00019	0.00344	CcSEcCtD
Captopril—Orthostatic hypotension—Niacin—atherosclerosis	0.000189	0.00342	CcSEcCtD
Captopril—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000188	0.0034	CcSEcCtD
Captopril—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000186	0.00337	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000184	0.00333	CcSEcCtD
Captopril—Muscular weakness—Niacin—atherosclerosis	0.000182	0.0033	CcSEcCtD
Captopril—Muscular weakness—Pravastatin—atherosclerosis	0.00018	0.00325	CcSEcCtD
Captopril—Erectile dysfunction—Simvastatin—atherosclerosis	0.000179	0.00324	CcSEcCtD
Captopril—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000178	0.00321	CcSEcCtD
Captopril—Jaundice—Ezetimibe—atherosclerosis	0.000177	0.00321	CcSEcCtD
Captopril—Eosinophilia—Pravastatin—atherosclerosis	0.000174	0.00315	CcSEcCtD
Captopril—Angina pectoris—Niacin—atherosclerosis	0.000174	0.00315	CcSEcCtD
Captopril—Pancreatitis—Pravastatin—atherosclerosis	0.000172	0.00312	CcSEcCtD
Captopril—REN—liver—atherosclerosis	0.000172	0.00322	CbGeAlD
Captopril—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000172	0.00311	CcSEcCtD
Captopril—Angina pectoris—Pravastatin—atherosclerosis	0.000171	0.0031	CcSEcCtD
Captopril—Jaundice—Simvastatin—atherosclerosis	0.000169	0.00306	CcSEcCtD
Captopril—Hepatitis—Lovastatin—atherosclerosis	0.000167	0.00301	CcSEcCtD
Captopril—Erectile dysfunction—Niacin—atherosclerosis	0.000165	0.00298	CcSEcCtD
Captopril—Hepatitis—Ezetimibe—atherosclerosis	0.000163	0.00296	CcSEcCtD
Captopril—Pharyngitis—Ezetimibe—atherosclerosis	0.000162	0.00293	CcSEcCtD
Captopril—Erectile dysfunction—Pravastatin—atherosclerosis	0.000162	0.00293	CcSEcCtD
Captopril—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000161	0.00291	CcSEcCtD
Captopril—Weight decreased—Pravastatin—atherosclerosis	0.000159	0.00288	CcSEcCtD
Captopril—MMP2—liver—atherosclerosis	0.000158	0.00296	CbGeAlD
Captopril—Erythema multiforme—Lovastatin—atherosclerosis	0.000157	0.00285	CcSEcCtD
Captopril—Angioedema—Rosuvastatin—atherosclerosis	0.000156	0.00283	CcSEcCtD
Captopril—Hepatitis—Simvastatin—atherosclerosis	0.000156	0.00282	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000155	0.00281	CcSEcCtD
Captopril—Stomatitis—Niacin—atherosclerosis	0.000155	0.00281	CcSEcCtD
Captopril—Jaundice—Niacin—atherosclerosis	0.000155	0.00281	CcSEcCtD
Captopril—Flushing—Lovastatin—atherosclerosis	0.000155	0.0028	CcSEcCtD
Captopril—Erythema multiforme—Ezetimibe—atherosclerosis	0.000154	0.00279	CcSEcCtD
Captopril—Jaundice—Pravastatin—atherosclerosis	0.000153	0.00277	CcSEcCtD
Captopril—Flushing—Ezetimibe—atherosclerosis	0.000152	0.00274	CcSEcCtD
Captopril—Cough—Rosuvastatin—atherosclerosis	0.000149	0.0027	CcSEcCtD
Captopril—Erythema multiforme—Simvastatin—atherosclerosis	0.000147	0.00266	CcSEcCtD
Captopril—Alopecia—Lovastatin—atherosclerosis	0.000147	0.00266	CcSEcCtD
Captopril—Arthralgia—Rosuvastatin—atherosclerosis	0.000146	0.00264	CcSEcCtD
Captopril—Myalgia—Rosuvastatin—atherosclerosis	0.000146	0.00264	CcSEcCtD
Captopril—Flushing—Simvastatin—atherosclerosis	0.000145	0.00262	CcSEcCtD
Captopril—Alopecia—Ezetimibe—atherosclerosis	0.000144	0.00261	CcSEcCtD
Captopril—Rhinitis—Niacin—atherosclerosis	0.000143	0.00259	CcSEcCtD
Captopril—Hepatitis—Niacin—atherosclerosis	0.000143	0.00259	CcSEcCtD
Captopril—Dysgeusia—Lovastatin—atherosclerosis	0.000142	0.00257	CcSEcCtD
Captopril—Rhinitis—Pravastatin—atherosclerosis	0.000141	0.00255	CcSEcCtD
Captopril—Hepatitis—Pravastatin—atherosclerosis	0.000141	0.00255	CcSEcCtD
Captopril—Confusional state—Rosuvastatin—atherosclerosis	0.000141	0.00255	CcSEcCtD
Captopril—Pharyngitis—Pravastatin—atherosclerosis	0.00014	0.00253	CcSEcCtD
Captopril—MMP9—liver—atherosclerosis	0.000138	0.00257	CbGeAlD
Captopril—Alopecia—Simvastatin—atherosclerosis	0.000138	0.00249	CcSEcCtD
Captopril—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000137	0.00247	CcSEcCtD
Captopril—Vision blurred—Lovastatin—atherosclerosis	0.000137	0.00247	CcSEcCtD
Captopril—ACE—connective tissue—atherosclerosis	0.000136	0.00255	CbGeAlD
Captopril—Ill-defined disorder—Lovastatin—atherosclerosis	0.000134	0.00243	CcSEcCtD
Captopril—Erythema multiforme—Pravastatin—atherosclerosis	0.000133	0.00241	CcSEcCtD
Captopril—Dysgeusia—Simvastatin—atherosclerosis	0.000133	0.0024	CcSEcCtD
Captopril—Flushing—Niacin—atherosclerosis	0.000133	0.0024	CcSEcCtD
Captopril—Angioedema—Lovastatin—atherosclerosis	0.000132	0.0024	CcSEcCtD
Captopril—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000132	0.00239	CcSEcCtD
Captopril—Anaemia—Ezetimibe—atherosclerosis	0.000131	0.00238	CcSEcCtD
Captopril—Malaise—Lovastatin—atherosclerosis	0.000131	0.00237	CcSEcCtD
Captopril—Flushing—Pravastatin—atherosclerosis	0.000131	0.00236	CcSEcCtD
Captopril—Angioedema—Ezetimibe—atherosclerosis	0.00013	0.00235	CcSEcCtD
Captopril—Malaise—Ezetimibe—atherosclerosis	0.000128	0.00232	CcSEcCtD
Captopril—Vision blurred—Simvastatin—atherosclerosis	0.000128	0.00231	CcSEcCtD
Captopril—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000127	0.0023	CcSEcCtD
Captopril—Alopecia—Niacin—atherosclerosis	0.000126	0.00229	CcSEcCtD
Captopril—Insomnia—Rosuvastatin—atherosclerosis	0.000126	0.00228	CcSEcCtD
Captopril—Ill-defined disorder—Simvastatin—atherosclerosis	0.000126	0.00228	CcSEcCtD
Captopril—Palpitations—Ezetimibe—atherosclerosis	0.000126	0.00227	CcSEcCtD
Captopril—Paraesthesia—Rosuvastatin—atherosclerosis	0.000125	0.00227	CcSEcCtD
Captopril—Anaemia—Simvastatin—atherosclerosis	0.000125	0.00227	CcSEcCtD
Captopril—Alopecia—Pravastatin—atherosclerosis	0.000124	0.00225	CcSEcCtD
Captopril—Cough—Ezetimibe—atherosclerosis	0.000124	0.00225	CcSEcCtD
Captopril—Angioedema—Simvastatin—atherosclerosis	0.000124	0.00224	CcSEcCtD
Captopril—Chest pain—Lovastatin—atherosclerosis	0.000123	0.00223	CcSEcCtD
Captopril—Myalgia—Lovastatin—atherosclerosis	0.000123	0.00223	CcSEcCtD
Captopril—Arthralgia—Lovastatin—atherosclerosis	0.000123	0.00223	CcSEcCtD
Captopril—Dyspepsia—Rosuvastatin—atherosclerosis	0.000123	0.00222	CcSEcCtD
Captopril—Malaise—Simvastatin—atherosclerosis	0.000122	0.00221	CcSEcCtD
Captopril—Tension—Niacin—atherosclerosis	0.000122	0.00221	CcSEcCtD
Captopril—Discomfort—Lovastatin—atherosclerosis	0.000122	0.00221	CcSEcCtD
Captopril—Myalgia—Ezetimibe—atherosclerosis	0.000121	0.00219	CcSEcCtD
Captopril—Arthralgia—Ezetimibe—atherosclerosis	0.000121	0.00219	CcSEcCtD
Captopril—Chest pain—Ezetimibe—atherosclerosis	0.000121	0.00219	CcSEcCtD
Captopril—Nervousness—Niacin—atherosclerosis	0.000121	0.00219	CcSEcCtD
Captopril—Dry mouth—Lovastatin—atherosclerosis	0.000121	0.00218	CcSEcCtD
Captopril—Tension—Pravastatin—atherosclerosis	0.00012	0.00218	CcSEcCtD
Captopril—F2—liver—atherosclerosis	0.00012	0.00224	CbGeAlD
Captopril—Dysgeusia—Pravastatin—atherosclerosis	0.00012	0.00217	CcSEcCtD
Captopril—Discomfort—Ezetimibe—atherosclerosis	0.00012	0.00216	CcSEcCtD
Captopril—Constipation—Rosuvastatin—atherosclerosis	0.000119	0.00216	CcSEcCtD
Captopril—Confusional state—Lovastatin—atherosclerosis	0.000119	0.00216	CcSEcCtD
Captopril—Nervousness—Pravastatin—atherosclerosis	0.000119	0.00215	CcSEcCtD
Captopril—ACE—cardiovascular system—atherosclerosis	0.000119	0.00222	CbGeAlD
Captopril—Dry mouth—Ezetimibe—atherosclerosis	0.000118	0.00214	CcSEcCtD
Captopril—Anaphylactic shock—Lovastatin—atherosclerosis	0.000118	0.00214	CcSEcCtD
Captopril—Vision blurred—Niacin—atherosclerosis	0.000117	0.00212	CcSEcCtD
Captopril—Confusional state—Ezetimibe—atherosclerosis	0.000117	0.00212	CcSEcCtD
Captopril—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000116	0.0021	CcSEcCtD
Captopril—Thrombocytopenia—Lovastatin—atherosclerosis	0.000116	0.0021	CcSEcCtD
Captopril—Vision blurred—Pravastatin—atherosclerosis	0.000116	0.00209	CcSEcCtD
Captopril—Arthralgia—Simvastatin—atherosclerosis	0.000115	0.00209	CcSEcCtD
Captopril—Myalgia—Simvastatin—atherosclerosis	0.000115	0.00209	CcSEcCtD
Captopril—Chest pain—Simvastatin—atherosclerosis	0.000115	0.00209	CcSEcCtD
Captopril—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000115	0.00208	CcSEcCtD
Captopril—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000114	0.00207	CcSEcCtD
Captopril—Discomfort—Simvastatin—atherosclerosis	0.000114	0.00206	CcSEcCtD
Captopril—Angioedema—Niacin—atherosclerosis	0.000114	0.00206	CcSEcCtD
Captopril—Ill-defined disorder—Pravastatin—atherosclerosis	0.000114	0.00206	CcSEcCtD
Captopril—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000114	0.00206	CcSEcCtD
Captopril—Anaemia—Pravastatin—atherosclerosis	0.000113	0.00205	CcSEcCtD
Captopril—Anorexia—Lovastatin—atherosclerosis	0.000113	0.00204	CcSEcCtD
Captopril—Angioedema—Pravastatin—atherosclerosis	0.000112	0.00203	CcSEcCtD
Captopril—Syncope—Niacin—atherosclerosis	0.000112	0.00202	CcSEcCtD
Captopril—Confusional state—Simvastatin—atherosclerosis	0.000112	0.00202	CcSEcCtD
Captopril—Anaphylactic shock—Simvastatin—atherosclerosis	0.000111	0.002	CcSEcCtD
Captopril—Malaise—Pravastatin—atherosclerosis	0.000111	0.002	CcSEcCtD
Captopril—Abdominal pain—Rosuvastatin—atherosclerosis	0.00011	0.002	CcSEcCtD
Captopril—Palpitations—Niacin—atherosclerosis	0.00011	0.00199	CcSEcCtD
Captopril—Loss of consciousness—Niacin—atherosclerosis	0.000109	0.00198	CcSEcCtD
Captopril—Cough—Niacin—atherosclerosis	0.000109	0.00197	CcSEcCtD
Captopril—Thrombocytopenia—Simvastatin—atherosclerosis	0.000108	0.00196	CcSEcCtD
Captopril—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000108	0.00195	CcSEcCtD
Captopril—Insomnia—Lovastatin—atherosclerosis	0.000107	0.00194	CcSEcCtD
Captopril—Cough—Pravastatin—atherosclerosis	0.000107	0.00194	CcSEcCtD
Captopril—Paraesthesia—Lovastatin—atherosclerosis	0.000106	0.00192	CcSEcCtD
Captopril—Myalgia—Niacin—atherosclerosis	0.000106	0.00192	CcSEcCtD
Captopril—Arthralgia—Niacin—atherosclerosis	0.000106	0.00192	CcSEcCtD
Captopril—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000106	0.00191	CcSEcCtD
Captopril—Anorexia—Simvastatin—atherosclerosis	0.000105	0.00191	CcSEcCtD
Captopril—Dyspnoea—Lovastatin—atherosclerosis	0.000105	0.00191	CcSEcCtD
Captopril—Insomnia—Ezetimibe—atherosclerosis	0.000105	0.0019	CcSEcCtD
Captopril—ACE—adipose tissue—atherosclerosis	0.000105	0.00195	CbGeAlD
Captopril—Arthralgia—Pravastatin—atherosclerosis	0.000104	0.00189	CcSEcCtD
Captopril—Chest pain—Pravastatin—atherosclerosis	0.000104	0.00189	CcSEcCtD
Captopril—Myalgia—Pravastatin—atherosclerosis	0.000104	0.00189	CcSEcCtD
Captopril—Paraesthesia—Ezetimibe—atherosclerosis	0.000104	0.00189	CcSEcCtD
Captopril—Dyspepsia—Lovastatin—atherosclerosis	0.000104	0.00188	CcSEcCtD
Captopril—Dry mouth—Niacin—atherosclerosis	0.000104	0.00188	CcSEcCtD
Captopril—Dyspnoea—Ezetimibe—atherosclerosis	0.000103	0.00187	CcSEcCtD
Captopril—Discomfort—Pravastatin—atherosclerosis	0.000103	0.00187	CcSEcCtD
Captopril—Decreased appetite—Lovastatin—atherosclerosis	0.000103	0.00186	CcSEcCtD
Captopril—SLC15A1—liver—atherosclerosis	0.000102	0.00191	CbGeAlD
Captopril—Dyspepsia—Ezetimibe—atherosclerosis	0.000102	0.00185	CcSEcCtD
Captopril—Fatigue—Lovastatin—atherosclerosis	0.000102	0.00185	CcSEcCtD
Captopril—Anaphylactic shock—Niacin—atherosclerosis	0.000102	0.00184	CcSEcCtD
Captopril—Constipation—Lovastatin—atherosclerosis	0.000101	0.00183	CcSEcCtD
Captopril—Confusional state—Pravastatin—atherosclerosis	0.000101	0.00183	CcSEcCtD
Captopril—Decreased appetite—Ezetimibe—atherosclerosis	0.000101	0.00183	CcSEcCtD
Captopril—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000101	0.00182	CcSEcCtD
Captopril—Asthenia—Rosuvastatin—atherosclerosis	0.0001	0.00181	CcSEcCtD
Captopril—Insomnia—Simvastatin—atherosclerosis	0.0001	0.00181	CcSEcCtD
Captopril—Anaphylactic shock—Pravastatin—atherosclerosis	0.0001	0.00181	CcSEcCtD
Captopril—Fatigue—Ezetimibe—atherosclerosis	0.0001	0.00181	CcSEcCtD
Captopril—Shock—Niacin—atherosclerosis	0.0001	0.00181	CcSEcCtD
Captopril—Paraesthesia—Simvastatin—atherosclerosis	9.94e-05	0.0018	CcSEcCtD
Captopril—Constipation—Ezetimibe—atherosclerosis	9.92e-05	0.0018	CcSEcCtD
Captopril—Tachycardia—Niacin—atherosclerosis	9.92e-05	0.00179	CcSEcCtD
Captopril—Pruritus—Rosuvastatin—atherosclerosis	9.88e-05	0.00179	CcSEcCtD
Captopril—Dyspnoea—Simvastatin—atherosclerosis	9.86e-05	0.00179	CcSEcCtD
Captopril—Thrombocytopenia—Pravastatin—atherosclerosis	9.79e-05	0.00177	CcSEcCtD
Captopril—Feeling abnormal—Lovastatin—atherosclerosis	9.75e-05	0.00176	CcSEcCtD
Captopril—Dyspepsia—Simvastatin—atherosclerosis	9.74e-05	0.00176	CcSEcCtD
Captopril—Anorexia—Niacin—atherosclerosis	9.68e-05	0.00175	CcSEcCtD
Captopril—Gastrointestinal pain—Lovastatin—atherosclerosis	9.67e-05	0.00175	CcSEcCtD
Captopril—Decreased appetite—Simvastatin—atherosclerosis	9.62e-05	0.00174	CcSEcCtD
Captopril—Feeling abnormal—Ezetimibe—atherosclerosis	9.56e-05	0.00173	CcSEcCtD
Captopril—Diarrhoea—Rosuvastatin—atherosclerosis	9.55e-05	0.00173	CcSEcCtD
Captopril—Fatigue—Simvastatin—atherosclerosis	9.54e-05	0.00173	CcSEcCtD
Captopril—Anorexia—Pravastatin—atherosclerosis	9.54e-05	0.00173	CcSEcCtD
Captopril—Hypotension—Niacin—atherosclerosis	9.49e-05	0.00172	CcSEcCtD
Captopril—Gastrointestinal pain—Ezetimibe—atherosclerosis	9.49e-05	0.00172	CcSEcCtD
Captopril—Constipation—Simvastatin—atherosclerosis	9.46e-05	0.00171	CcSEcCtD
Captopril—ABCB1—blood vessel—atherosclerosis	9.37e-05	0.00175	CbGeAlD
Captopril—Abdominal pain—Lovastatin—atherosclerosis	9.35e-05	0.00169	CcSEcCtD
Captopril—Body temperature increased—Lovastatin—atherosclerosis	9.35e-05	0.00169	CcSEcCtD
Captopril—Musculoskeletal discomfort—Niacin—atherosclerosis	9.26e-05	0.00168	CcSEcCtD
Captopril—Dizziness—Rosuvastatin—atherosclerosis	9.23e-05	0.00167	CcSEcCtD
Captopril—Insomnia—Niacin—atherosclerosis	9.19e-05	0.00166	CcSEcCtD
Captopril—Body temperature increased—Ezetimibe—atherosclerosis	9.17e-05	0.00166	CcSEcCtD
Captopril—Abdominal pain—Ezetimibe—atherosclerosis	9.17e-05	0.00166	CcSEcCtD
Captopril—Paraesthesia—Niacin—atherosclerosis	9.12e-05	0.00165	CcSEcCtD
Captopril—Feeling abnormal—Simvastatin—atherosclerosis	9.12e-05	0.00165	CcSEcCtD
Captopril—Musculoskeletal discomfort—Pravastatin—atherosclerosis	9.11e-05	0.00165	CcSEcCtD
Captopril—Dyspnoea—Niacin—atherosclerosis	9.06e-05	0.00164	CcSEcCtD
Captopril—Gastrointestinal pain—Simvastatin—atherosclerosis	9.05e-05	0.00164	CcSEcCtD
Captopril—Insomnia—Pravastatin—atherosclerosis	9.05e-05	0.00164	CcSEcCtD
Captopril—Somnolence—Niacin—atherosclerosis	9.03e-05	0.00163	CcSEcCtD
Captopril—Paraesthesia—Pravastatin—atherosclerosis	8.98e-05	0.00163	CcSEcCtD
Captopril—Dyspepsia—Niacin—atherosclerosis	8.94e-05	0.00162	CcSEcCtD
Captopril—Dyspnoea—Pravastatin—atherosclerosis	8.92e-05	0.00161	CcSEcCtD
Captopril—Decreased appetite—Niacin—atherosclerosis	8.83e-05	0.0016	CcSEcCtD
Captopril—Dyspepsia—Pravastatin—atherosclerosis	8.81e-05	0.00159	CcSEcCtD
Captopril—Rash—Rosuvastatin—atherosclerosis	8.8e-05	0.00159	CcSEcCtD
Captopril—Dermatitis—Rosuvastatin—atherosclerosis	8.79e-05	0.00159	CcSEcCtD
Captopril—Abdominal pain—Simvastatin—atherosclerosis	8.75e-05	0.00158	CcSEcCtD
Captopril—Body temperature increased—Simvastatin—atherosclerosis	8.75e-05	0.00158	CcSEcCtD
Captopril—Headache—Rosuvastatin—atherosclerosis	8.74e-05	0.00158	CcSEcCtD
Captopril—Decreased appetite—Pravastatin—atherosclerosis	8.7e-05	0.00157	CcSEcCtD
Captopril—Fatigue—Pravastatin—atherosclerosis	8.62e-05	0.00156	CcSEcCtD
Captopril—Constipation—Pravastatin—atherosclerosis	8.55e-05	0.00155	CcSEcCtD
Captopril—Asthenia—Lovastatin—atherosclerosis	8.49e-05	0.00154	CcSEcCtD
Captopril—Pruritus—Lovastatin—atherosclerosis	8.37e-05	0.00151	CcSEcCtD
Captopril—Asthenia—Ezetimibe—atherosclerosis	8.32e-05	0.00151	CcSEcCtD
Captopril—Gastrointestinal pain—Niacin—atherosclerosis	8.31e-05	0.0015	CcSEcCtD
Captopril—Nausea—Rosuvastatin—atherosclerosis	8.29e-05	0.0015	CcSEcCtD
Captopril—Feeling abnormal—Pravastatin—atherosclerosis	8.24e-05	0.00149	CcSEcCtD
Captopril—Pruritus—Ezetimibe—atherosclerosis	8.21e-05	0.00149	CcSEcCtD
Captopril—Gastrointestinal pain—Pravastatin—atherosclerosis	8.18e-05	0.00148	CcSEcCtD
Captopril—Diarrhoea—Lovastatin—atherosclerosis	8.09e-05	0.00146	CcSEcCtD
Captopril—Abdominal pain—Niacin—atherosclerosis	8.03e-05	0.00145	CcSEcCtD
Captopril—Body temperature increased—Niacin—atherosclerosis	8.03e-05	0.00145	CcSEcCtD
Captopril—Asthenia—Simvastatin—atherosclerosis	7.94e-05	0.00144	CcSEcCtD
Captopril—Diarrhoea—Ezetimibe—atherosclerosis	7.94e-05	0.00144	CcSEcCtD
Captopril—Body temperature increased—Pravastatin—atherosclerosis	7.91e-05	0.00143	CcSEcCtD
Captopril—Abdominal pain—Pravastatin—atherosclerosis	7.91e-05	0.00143	CcSEcCtD
Captopril—Pruritus—Simvastatin—atherosclerosis	7.83e-05	0.00142	CcSEcCtD
Captopril—Dizziness—Lovastatin—atherosclerosis	7.82e-05	0.00142	CcSEcCtD
Captopril—Dizziness—Ezetimibe—atherosclerosis	7.67e-05	0.00139	CcSEcCtD
Captopril—ALB—liver—atherosclerosis	7.67e-05	0.00143	CbGeAlD
Captopril—Diarrhoea—Simvastatin—atherosclerosis	7.57e-05	0.00137	CcSEcCtD
Captopril—Vomiting—Lovastatin—atherosclerosis	7.52e-05	0.00136	CcSEcCtD
Captopril—Rash—Lovastatin—atherosclerosis	7.46e-05	0.00135	CcSEcCtD
Captopril—Dermatitis—Lovastatin—atherosclerosis	7.45e-05	0.00135	CcSEcCtD
Captopril—Headache—Lovastatin—atherosclerosis	7.41e-05	0.00134	CcSEcCtD
Captopril—Vomiting—Ezetimibe—atherosclerosis	7.38e-05	0.00134	CcSEcCtD
Captopril—ACE—liver—atherosclerosis	7.34e-05	0.00137	CbGeAlD
Captopril—Dizziness—Simvastatin—atherosclerosis	7.32e-05	0.00132	CcSEcCtD
Captopril—Rash—Ezetimibe—atherosclerosis	7.32e-05	0.00132	CcSEcCtD
Captopril—Dermatitis—Ezetimibe—atherosclerosis	7.31e-05	0.00132	CcSEcCtD
Captopril—Asthenia—Niacin—atherosclerosis	7.29e-05	0.00132	CcSEcCtD
Captopril—Headache—Ezetimibe—atherosclerosis	7.27e-05	0.00132	CcSEcCtD
Captopril—Pruritus—Niacin—atherosclerosis	7.19e-05	0.0013	CcSEcCtD
Captopril—Asthenia—Pravastatin—atherosclerosis	7.18e-05	0.0013	CcSEcCtD
Captopril—Pruritus—Pravastatin—atherosclerosis	7.08e-05	0.00128	CcSEcCtD
Captopril—Vomiting—Simvastatin—atherosclerosis	7.04e-05	0.00127	CcSEcCtD
Captopril—Nausea—Lovastatin—atherosclerosis	7.03e-05	0.00127	CcSEcCtD
Captopril—Rash—Simvastatin—atherosclerosis	6.98e-05	0.00126	CcSEcCtD
Captopril—Dermatitis—Simvastatin—atherosclerosis	6.97e-05	0.00126	CcSEcCtD
Captopril—Diarrhoea—Niacin—atherosclerosis	6.95e-05	0.00126	CcSEcCtD
Captopril—Headache—Simvastatin—atherosclerosis	6.93e-05	0.00125	CcSEcCtD
Captopril—Nausea—Ezetimibe—atherosclerosis	6.89e-05	0.00125	CcSEcCtD
Captopril—Diarrhoea—Pravastatin—atherosclerosis	6.84e-05	0.00124	CcSEcCtD
Captopril—Dizziness—Niacin—atherosclerosis	6.72e-05	0.00122	CcSEcCtD
Captopril—Dizziness—Pravastatin—atherosclerosis	6.61e-05	0.0012	CcSEcCtD
Captopril—Nausea—Simvastatin—atherosclerosis	6.57e-05	0.00119	CcSEcCtD
Captopril—Vomiting—Niacin—atherosclerosis	6.46e-05	0.00117	CcSEcCtD
Captopril—Rash—Niacin—atherosclerosis	6.41e-05	0.00116	CcSEcCtD
Captopril—Dermatitis—Niacin—atherosclerosis	6.4e-05	0.00116	CcSEcCtD
Captopril—Headache—Niacin—atherosclerosis	6.36e-05	0.00115	CcSEcCtD
Captopril—Vomiting—Pravastatin—atherosclerosis	6.36e-05	0.00115	CcSEcCtD
Captopril—Rash—Pravastatin—atherosclerosis	6.31e-05	0.00114	CcSEcCtD
Captopril—Dermatitis—Pravastatin—atherosclerosis	6.3e-05	0.00114	CcSEcCtD
Captopril—Headache—Pravastatin—atherosclerosis	6.27e-05	0.00113	CcSEcCtD
Captopril—Nausea—Niacin—atherosclerosis	6.03e-05	0.00109	CcSEcCtD
Captopril—Nausea—Pravastatin—atherosclerosis	5.94e-05	0.00108	CcSEcCtD
Captopril—ABCB1—cardiovascular system—atherosclerosis	4.18e-05	0.00078	CbGeAlD
Captopril—ABCB1—adipose tissue—atherosclerosis	3.68e-05	0.000688	CbGeAlD
Captopril—CYP2D6—liver—atherosclerosis	3.59e-05	0.000671	CbGeAlD
Captopril—ABCB1—liver—atherosclerosis	2.58e-05	0.000482	CbGeAlD
Captopril—MMP9—Signaling Pathways—PRKCG—atherosclerosis	3.53e-06	5.45e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.47e-06	5.35e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SPP1—atherosclerosis	3.44e-06	5.31e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—APOB—atherosclerosis	3.44e-06	5.3e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—TGFB1—atherosclerosis	3.43e-06	5.3e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KNG1—atherosclerosis	3.43e-06	5.29e-05	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—atherosclerosis	3.42e-06	5.27e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGTR1—atherosclerosis	3.41e-06	5.26e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—FABP4—atherosclerosis	3.4e-06	5.25e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—LCAT—atherosclerosis	3.4e-06	5.25e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	3.37e-06	5.19e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL2—atherosclerosis	3.34e-06	5.16e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOA4—atherosclerosis	3.34e-06	5.16e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PLG—atherosclerosis	3.32e-06	5.12e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP7A1—atherosclerosis	3.28e-06	5.06e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PRKCG—atherosclerosis	3.19e-06	4.92e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PDGFB—atherosclerosis	3.18e-06	4.91e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ABCG1—atherosclerosis	3.17e-06	4.89e-05	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—atherosclerosis	3.15e-06	4.86e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SOCS3—atherosclerosis	3.15e-06	4.85e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.13e-06	4.83e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	3.12e-06	4.82e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—CD36—atherosclerosis	3.12e-06	4.81e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGT—atherosclerosis	3.11e-06	4.79e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.11e-06	4.79e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	3.07e-06	4.74e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—LEP—atherosclerosis	3.04e-06	4.7e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APOE—atherosclerosis	3.04e-06	4.7e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP3—atherosclerosis	3.04e-06	4.69e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP27A1—atherosclerosis	3.03e-06	4.68e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF2—atherosclerosis	3.02e-06	4.67e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CAV1—atherosclerosis	3.02e-06	4.65e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APOA1—atherosclerosis	3.01e-06	4.64e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.99e-06	4.61e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.99e-06	4.61e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—FABP4—atherosclerosis	2.98e-06	4.6e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LCAT—atherosclerosis	2.98e-06	4.6e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	2.97e-06	4.59e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.95e-06	4.55e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOB—atherosclerosis	2.94e-06	4.53e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOA4—atherosclerosis	2.93e-06	4.52e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.91e-06	4.5e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL8—atherosclerosis	2.91e-06	4.49e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ESR1—atherosclerosis	2.91e-06	4.48e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EDN1—atherosclerosis	2.89e-06	4.46e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	2.88e-06	4.44e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ALOX15—atherosclerosis	2.88e-06	4.44e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ALOX5AP—atherosclerosis	2.88e-06	4.44e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PLA2G2A—atherosclerosis	2.88e-06	4.44e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOA2—atherosclerosis	2.88e-06	4.44e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.88e-06	4.44e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PDGFB—atherosclerosis	2.88e-06	4.44e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—F2—atherosclerosis	2.87e-06	4.43e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL5—atherosclerosis	2.87e-06	4.42e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—MMP1—atherosclerosis	2.84e-06	4.39e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCG5—atherosclerosis	2.84e-06	4.38e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.84e-06	4.38e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.84e-06	4.37e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LCAT—atherosclerosis	2.81e-06	4.34e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—FABP4—atherosclerosis	2.81e-06	4.34e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LPL—atherosclerosis	2.8e-06	4.33e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOA4—atherosclerosis	2.76e-06	4.26e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CG—atherosclerosis	2.75e-06	4.24e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—LPA—atherosclerosis	2.74e-06	4.23e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PRKCG—atherosclerosis	2.73e-06	4.21e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—CAV1—atherosclerosis	2.73e-06	4.2e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	2.72e-06	4.2e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.72e-06	4.2e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—APOA1—atherosclerosis	2.72e-06	4.19e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.71e-06	4.18e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.68e-06	4.14e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP27A1—atherosclerosis	2.66e-06	4.1e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—BGN—atherosclerosis	2.66e-06	4.1e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SPP1—atherosclerosis	2.66e-06	4.1e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL8—atherosclerosis	2.64e-06	4.08e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	2.64e-06	4.08e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.64e-06	4.07e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOA5—atherosclerosis	2.63e-06	4.06e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.61e-06	4.02e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.6e-06	4.02e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—INS—atherosclerosis	2.6e-06	4.01e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—F2—atherosclerosis	2.59e-06	4e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS2—atherosclerosis	2.56e-06	3.95e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL2—atherosclerosis	2.56e-06	3.95e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.56e-06	3.94e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PLA2G1B—atherosclerosis	2.53e-06	3.91e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALOX15—atherosclerosis	2.52e-06	3.89e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PLA2G2A—atherosclerosis	2.52e-06	3.89e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALOX5AP—atherosclerosis	2.52e-06	3.89e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOA2—atherosclerosis	2.52e-06	3.89e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1—atherosclerosis	2.52e-06	3.88e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.51e-06	3.87e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.51e-06	3.87e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.5e-06	3.86e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ABCG5—atherosclerosis	2.49e-06	3.84e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CG—atherosclerosis	2.48e-06	3.83e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.48e-06	3.83e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.48e-06	3.82e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PDGFB—atherosclerosis	2.46e-06	3.79e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ALOX5—atherosclerosis	2.45e-06	3.77e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2.43e-06	3.75e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LPA—atherosclerosis	2.4e-06	3.71e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGT—atherosclerosis	2.4e-06	3.7e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SERPINE1—atherosclerosis	2.39e-06	3.68e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—atherosclerosis	2.39e-06	3.68e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.38e-06	3.66e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.38e-06	3.66e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.38e-06	3.66e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOA2—atherosclerosis	2.38e-06	3.66e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.35e-06	3.63e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOE—atherosclerosis	2.35e-06	3.63e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LEP—atherosclerosis	2.35e-06	3.63e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.35e-06	3.62e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BGN—atherosclerosis	2.33e-06	3.59e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CAV1—atherosclerosis	2.33e-06	3.59e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOA1—atherosclerosis	2.32e-06	3.58e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOA5—atherosclerosis	2.31e-06	3.56e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOS3—atherosclerosis	2.28e-06	3.52e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IGF1—atherosclerosis	2.27e-06	3.51e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LPA—atherosclerosis	2.27e-06	3.5e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.26e-06	3.49e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ESR1—atherosclerosis	2.24e-06	3.46e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PLA2G1B—atherosclerosis	2.22e-06	3.42e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.2e-06	3.39e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BGN—atherosclerosis	2.19e-06	3.39e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NAMPT—atherosclerosis	2.19e-06	3.38e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.18e-06	3.36e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—LIPC—atherosclerosis	2.18e-06	3.36e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOA5—atherosclerosis	2.17e-06	3.35e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOC3—atherosclerosis	2.17e-06	3.34e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—SERPINE1—atherosclerosis	2.16e-06	3.33e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—LDLR—atherosclerosis	2.15e-06	3.32e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALOX5—atherosclerosis	2.14e-06	3.31e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CG—atherosclerosis	2.12e-06	3.27e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CETP—atherosclerosis	2.1e-06	3.24e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.09e-06	3.23e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.06e-06	3.18e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS3—atherosclerosis	2.06e-06	3.18e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAPK3—atherosclerosis	2.03e-06	3.13e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—atherosclerosis	2.02e-06	3.12e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.02e-06	3.12e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SCARB1—atherosclerosis	2.01e-06	3.11e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—INS—atherosclerosis	2.01e-06	3.1e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL2—atherosclerosis	1.98e-06	3.05e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1—atherosclerosis	1.94e-06	3e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NAMPT—atherosclerosis	1.92e-06	2.97e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LIPC—atherosclerosis	1.91e-06	2.95e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HMGCR—atherosclerosis	1.9e-06	2.93e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOC3—atherosclerosis	1.9e-06	2.93e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LDLR—atherosclerosis	1.89e-06	2.91e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SERPINE1—atherosclerosis	1.84e-06	2.84e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CETP—atherosclerosis	1.84e-06	2.84e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.84e-06	2.83e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.81e-06	2.79e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NFKB1—atherosclerosis	1.81e-06	2.79e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.81e-06	2.79e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LIPC—atherosclerosis	1.8e-06	2.78e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOC3—atherosclerosis	1.79e-06	2.76e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK8—atherosclerosis	1.78e-06	2.74e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LDLR—atherosclerosis	1.78e-06	2.74e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SCARB1—atherosclerosis	1.76e-06	2.72e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOS3—atherosclerosis	1.76e-06	2.72e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CETP—atherosclerosis	1.74e-06	2.68e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.72e-06	2.65e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCA1—atherosclerosis	1.7e-06	2.62e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HMGCR—atherosclerosis	1.67e-06	2.57e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.66e-06	2.57e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—atherosclerosis	1.64e-06	2.53e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.63e-06	2.52e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT3—atherosclerosis	1.63e-06	2.51e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.57e-06	2.42e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—atherosclerosis	1.56e-06	2.41e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK3—atherosclerosis	1.55e-06	2.4e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—atherosclerosis	1.51e-06	2.33e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—atherosclerosis	1.51e-06	2.33e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ABCA1—atherosclerosis	1.49e-06	2.29e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—atherosclerosis	1.49e-06	2.29e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—atherosclerosis	1.48e-06	2.29e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HMOX1—atherosclerosis	1.45e-06	2.24e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—atherosclerosis	1.41e-06	2.18e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAPK3—atherosclerosis	1.4e-06	2.17e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.4e-06	2.16e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NFKB1—atherosclerosis	1.4e-06	2.16e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOB—atherosclerosis	1.39e-06	2.15e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK8—atherosclerosis	1.37e-06	2.12e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—atherosclerosis	1.37e-06	2.11e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—atherosclerosis	1.36e-06	2.1e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTM1—atherosclerosis	1.36e-06	2.09e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—LPL—atherosclerosis	1.33e-06	2.05e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GPX1—atherosclerosis	1.3e-06	2e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HMOX1—atherosclerosis	1.27e-06	1.97e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—atherosclerosis	1.27e-06	1.96e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CD36—atherosclerosis	1.26e-06	1.95e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT3—atherosclerosis	1.26e-06	1.94e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOB—atherosclerosis	1.22e-06	1.88e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.2e-06	1.85e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK3—atherosclerosis	1.2e-06	1.85e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MTHFR—atherosclerosis	1.2e-06	1.85e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTM1—atherosclerosis	1.19e-06	1.83e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARA—atherosclerosis	1.18e-06	1.81e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LPL—atherosclerosis	1.17e-06	1.8e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—atherosclerosis	1.16e-06	1.8e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOB—atherosclerosis	1.15e-06	1.77e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AGT—atherosclerosis	1.14e-06	1.76e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPX1—atherosclerosis	1.14e-06	1.75e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—atherosclerosis	1.14e-06	1.75e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.12e-06	1.73e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOE—atherosclerosis	1.12e-06	1.72e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CD36—atherosclerosis	1.11e-06	1.71e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CAV1—atherosclerosis	1.1e-06	1.7e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOA1—atherosclerosis	1.1e-06	1.7e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LPL—atherosclerosis	1.1e-06	1.69e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPX1—atherosclerosis	1.07e-06	1.65e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTHFR—atherosclerosis	1.05e-06	1.62e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—atherosclerosis	1.05e-06	1.62e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CD36—atherosclerosis	1.04e-06	1.61e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARA—atherosclerosis	1.03e-06	1.59e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CG—atherosclerosis	1.01e-06	1.55e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AGT—atherosclerosis	9.97e-07	1.54e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTHFR—atherosclerosis	9.89e-07	1.53e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOE—atherosclerosis	9.77e-07	1.51e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARG—atherosclerosis	9.71e-07	1.5e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARA—atherosclerosis	9.7e-07	1.5e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CAV1—atherosclerosis	9.68e-07	1.49e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOA1—atherosclerosis	9.66e-07	1.49e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—INS—atherosclerosis	9.53e-07	1.47e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—atherosclerosis	9.47e-07	1.46e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AGT—atherosclerosis	9.4e-07	1.45e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOE—atherosclerosis	9.21e-07	1.42e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CAV1—atherosclerosis	9.12e-07	1.41e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOA1—atherosclerosis	9.1e-07	1.4e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CG—atherosclerosis	8.82e-07	1.36e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—atherosclerosis	8.77e-07	1.35e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARG—atherosclerosis	8.51e-07	1.31e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NOS3—atherosclerosis	8.35e-07	1.29e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—INS—atherosclerosis	8.35e-07	1.29e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CG—atherosclerosis	8.31e-07	1.28e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—atherosclerosis	8.09e-07	1.25e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARG—atherosclerosis	8.02e-07	1.24e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—INS—atherosclerosis	7.87e-07	1.21e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—atherosclerosis	7.65e-07	1.18e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—atherosclerosis	7.64e-07	1.18e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NOS3—atherosclerosis	7.32e-07	1.13e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—atherosclerosis	7.21e-07	1.11e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NOS3—atherosclerosis	6.9e-07	1.06e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—atherosclerosis	6.7e-07	1.03e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—atherosclerosis	6.31e-07	9.73e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—atherosclerosis	3.84e-07	5.92e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—atherosclerosis	3.36e-07	5.19e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—atherosclerosis	3.17e-07	4.89e-06	CbGpPWpGaD
